NHI price review for bio equivalent drugs shortened within a month .

The KFDA, in the brief talk meeing with the HIRA on Nov. 8, decided to give additional benefit plans to the 30% incentive program for the pharmacists who substitute prescriptions for other bio equivalent drugs to boost their substitutive dispensing practices and to save the NHI finance.

The KFDA set up the incentive scheme for the physicians and pharmacists to prescribe and dispense other su...